IVOG · Vanguard S&P Mid-Cap 400 Growth ETF

Equity fundTracks an index0.10% fee$1.7bnSince Sep 9, 2010Fund page at the issuer ↗SEC filings ↗

IVOG tracks an index and returned +16.9% over the past year.

+16.9%
Total return, 1 year
0.10%
Expense ratio
250
Holdings
−6.1%
Below its high
WindowTotal returnS&P 500Gap to S&P 500Gap to Nasdaq-100
3M Jul 2 – Oct 2, 2026−2.8%+3.6%−6.4 pts−8.1 pts
6M Apr 2 – Oct 2, 2026+10.1%+17.9%−7.8 pts−18.3 pts
1Y Oct 2, 2025 – Oct 2, 2026+16.9%+16.2%+0.6 pts−7.5 pts
3Y Oct 3, 2023 – Oct 2, 2026+62.6%+89.3%−26.7 pts−52.2 pts
Since listing Sep 9, 2010 – Oct 2, 2026+530.4%+824.6%−294.1 pts−1225.5 pts

IVOG over each window to Oct 2, 2026. Every figure is an ETFIQ calculation. Source: ETFIQ.

IVOG top ten by weight, 14.4% of its 250 equity positions, from the holdings filed for Aug 31, 2026. An index fund holds what the index holds, so this is the index. Source: the fund’s SEC filing.

Twilio Inc TWLO 1.94%
TechnipFMC PLC FTI 1.69%
Everpure Inc P 1.59%
Okta Inc OKTA 1.57%
ATI Inc ATI 1.51%
XPO Inc XPO 1.23%
United Therapeutics Corp UTHR 1.17%
Curtiss-Wright Corp CW 1.16%

In plain words

IVOG tracks an index. Over the year to Oct 2, 2026 it returned +16.9% with distributions reinvested, against +16.2% for the S&P 500 and +24.3% for the Nasdaq-100. The prospectus expense ratio is 0.10% a year. By its holdings published by its issuer as of Aug 31, 2026, 3% of the fund by weight is stocks the S&P 500 also holds, across 250 positions, with the top ten at 14.4%. It sat 6.1% below its high of Aug 14, 2026 on Oct 2, 2026.
What it tracksnot read by ETFIQ
Fund typeEquity fund
Category (ETFIQ)Stocks · U.S. mid-cap blend
Expense ratio (485BPOS XBRL, Dec 19, 2025)0.10%
Price$139.37
Listed sinceSep 9, 2010
Net assets (the issuer’s own figure for this ETF, month end, as of Sep 30, 2026)$1.7bn
Below its high (ETFIQ)−6.1%
Holdings250
Top ten weight14.4%
Holdings as of (the issuer’s month-end file)Aug 31, 2026
Already in the S&P 500, by weight (ETFIQ)3.0%
Active share vs the S&P 500 (ETFIQ)99.9%
Already in the Nasdaq-100, by weight (ETFIQ)0.0%
ETFIQ links to the documents behind every figure. It is not affiliated with any issuer, and a link is not an endorsement.

Questions people ask about IVOG

How has IVOG performed?
Over the year to Oct 2, 2026, IVOG returned +16.9% with distributions reinvested, against +16.2% for the S&P 500. Over three years the figure is +62.6%.
What does IVOG cost?
The prospectus expense ratio is 0.10% a year.
What does IVOG hold?
250 positions as published by its issuer as of Aug 31, 2026, with the top ten at 14.4% of the fund. 3% of its weight is in stocks the S&P 500 also holds.
How far is IVOG below its high?
6.1% below its high of Aug 14, 2026, measured on the reinvested series to Oct 2, 2026.
Sources and dates
Prices, IVOG and S&P 500Tiingo end-of-day · Oct 2, 2026
Net assets, $1.7bnThe issuer’s own figure for this ETF, month end · Sep 30, 2026

ETFIQ links to the documents behind every figure. It is not affiliated with any issuer, and a link is not an endorsement.

ETFIQ covers core, leveraged and inverse, buffer, thematic, option-income, alternatives and spot crypto ETFs. This fund is here because the other funds here are measured against it and portfolios hold it. ETFIQ is an independent publisher and makes no recommendations. Standards and sources

Cite this page

ETFIQ, IVOG, core fund, data as of Oct 2, 2026. https://etfiq.com/funds/ivog

Free to use with attribution; the underlying files are at Open data.